Beta-blocker pharmacogenetics in heart failure.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Works matching IS 13824147 AND DT 2010 AND VI 15 AND IP 3
Results: 9
1
2
Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.
- Published in:
- 2010
- By:
- Publication type:
- journal article
3
β-Blocker pharmacogenetics in heart failure.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 187, doi. 10.1007/s10741-008-9094-x
- By:
- Publication type:
- Article
4
Understanding the pharmacogenetic approach to warfarin dosing.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 239, doi. 10.1007/s10741-008-9115-9
- By:
- Publication type:
- Article
5
Genetic variation in the natriuretic peptide system and heart failure.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 219, doi. 10.1007/s10741-008-9113-y
- By:
- Publication type:
- Article
6
Renin–angiotensin–aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 209, doi. 10.1007/s10741-008-9092-z
- By:
- Publication type:
- Article
7
PPAR transcriptional activator complex polymorphisms and the promise of individualized therapy for heart failure.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 197, doi. 10.1007/s10741-008-9114-x
- By:
- Publication type:
- Article
8
Using patient DNA to optimize therapy in heart failure patients: a move toward perfection.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 183, doi. 10.1007/s10741-009-9150-1
- By:
- Publication type:
- Article
9
Genomics, heart failure and sudden cardiac death.
- Published in:
- Heart Failure Reviews, 2010, v. 15, n. 3, p. 229, doi. 10.1007/s10741-008-9095-9
- By:
- Publication type:
- Article